Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa for Rehabilitation After Colorectal Cancer Surgery
NCT00122720Phase 4Completed
- Sponsor
- Regionshospitalet Herning
- Start
- Jun 2003
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in colorectal cancer (CRC) comparing Darbepoetin Alfa with Placebo (2 arms). Primary endpoint: Functional capacity measured by postoperative fatigue, work capacity, balance, and quality of life. Started Jun 2003; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00122720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122720.